NRGene Technologies Balance Sheet Health
Financial Health criteria checks 4/6
NRGene Technologies has a total shareholder equity of $5.4M and total debt of $656.0K, which brings its debt-to-equity ratio to 12.2%. Its total assets and total liabilities are $8.4M and $3.0M respectively.
Key information
12.2%
Debt to equity ratio
US$656.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.01m |
| Equity | US$5.38m |
| Total liabilities | US$3.03m |
| Total assets | US$8.41m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NRGN's short term assets ($4.1M) exceed its short term liabilities ($2.4M).
Long Term Liabilities: NRGN's short term assets ($4.1M) exceed its long term liabilities ($580.0K).
Debt to Equity History and Analysis
Debt Level: NRGN has more cash than its total debt.
Reducing Debt: NRGN had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NRGN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23% each year